253 related articles for article (PubMed ID: 5110789)
1. [Attempt at treating parkinsonism with L-dopa and Artane].
Stelmasiak Z; Lackowska H; Maksymowicz B
Pol Tyg Lek; 1971 Aug; 26(34):1325-6. PubMed ID: 5110789
[No Abstract] [Full Text] [Related]
2. [Effect of a combined L-Dopa and decarboxylase inhibitor (Ro 4-4602) therapy in parkinsonism patients. Quantitative analysis of bradykinesia using reaction times].
Kaufmann W; Butz P; Wiesendanger M
Dtsch Z Nervenheilkd; 1969 Dec; 197(1):85-100. PubMed ID: 5364658
[No Abstract] [Full Text] [Related]
3. [Therapeutic effects of L-dopa and trihexyphenidyl in Parkinson's disease--an examination by a double blind method].
Hirayama K; Uono M; Nakanishi T; Kato N; Nagao Y
Shinkei Kenkyu No Shimpo; 1971; 15(1):267-85. PubMed ID: 4937721
[No Abstract] [Full Text] [Related]
4. [Comparative value of L-dopa, amantadine, anticholinergics, and their combinations in parkinsonian syndromes].
Ciuca I; Bulandra R; Serbanesco A; Ninosu N
Rev Neurol (Paris); 1972 Aug; 127(2):305-8. PubMed ID: 4672049
[No Abstract] [Full Text] [Related]
5. [Factors which influence infavourably l-dopa treatment].
Presthus J
Tidsskr Nor Laegeforen; 1973 Oct; 93(28):2115-6. PubMed ID: 4590071
[No Abstract] [Full Text] [Related]
6. 3-O-Methyldopa, L-dopa, and trihexyphenidyl in the treatment of Parkinson's disease.
Muenter MD; Dinapoli RP; Sharpless NS; Tyce GM
Mayo Clin Proc; 1973 Mar; 48(3):173-83. PubMed ID: 4570387
[No Abstract] [Full Text] [Related]
7. Parkinsonism and dopa.
N Z Med J; 1969 May; 69(444):306-7. PubMed ID: 5256210
[No Abstract] [Full Text] [Related]
8. [Association of L-dopa and other therapeutic methods in treatment of parkinsonian syndromes].
Mingrino S
Sist Nerv; 1970; 22(2):212-5. PubMed ID: 4926920
[No Abstract] [Full Text] [Related]
9. L-dopa in the treatment of Parkinsonism.
Brezný I; Buranová D; Cernácek J; Trávniková M
Act Nerv Super (Praha); 1972; 14(2):96. PubMed ID: 5040182
[No Abstract] [Full Text] [Related]
10. [Utility of L-dopa in the treatment of Parkinson's disease and parkinsonism-like diseases].
Herskovits E; Matera R; Gacitua EF
Medicina (B Aires); 1972; 32(1):10-4. PubMed ID: 5019629
[No Abstract] [Full Text] [Related]
11. [Evaluation of L-DOPA in Parkinsonism with special reference to the study by double-blind method].
Okajima T; Kubota A; Nakahara N; Takeda S; Shimomura K
Naika; 1972; 29(2):335-43. PubMed ID: 4552443
[No Abstract] [Full Text] [Related]
12. MK 486 and levodopa in treatment of Parkinsonism.
Lieberman AN; Derby BM; Feigenson J; Goodgold A; Nesbitte J; Resurreccion EC; Valdivia F
Dis Nerv Syst; 1973; 34(4):167-71. PubMed ID: 4711885
[No Abstract] [Full Text] [Related]
13. [Action of amantadine HCl alone and in combination with L-dopa on parkinsonism].
Danielczyk W; Korten JJ
Med Monatsschr; 1971 Oct; 25(10):472-9. PubMed ID: 5122447
[No Abstract] [Full Text] [Related]
14. [Present-day treatment of parkinsonism in the aged].
Siegfried J
Schweiz Rundsch Med Prax; 1973 Oct; 62(40):1202-3. PubMed ID: 4754539
[No Abstract] [Full Text] [Related]
15. [Potentiation of L-Dopa in parkinsonism by means of an inhibitor of peripheral decarboxylation].
Court J; Kase JC; Mena I; Palacios E
Rev Med Chil; 1973 Jun; 101(6):452-5. PubMed ID: 4764560
[No Abstract] [Full Text] [Related]
16. The pharmacology of parkinsonism (a review).
Klawans HL
Dis Nerv Syst; 1968 Dec; 29(12):805-16. PubMed ID: 4388368
[No Abstract] [Full Text] [Related]
17. [Experimental results of the combined treatment of parkinsonism using L-DOPA and a decarboxylase inhibitory agent (Ro 4-4602)].
Birkmayer W
Wien Klin Wochenschr; 1969 Sep; 81(39):677-9. PubMed ID: 5344299
[No Abstract] [Full Text] [Related]
18. [Advances in L-DOPA therapy for parkinsonism through combination with a decarboxylase inhibitor. Results of a long-term study].
Wälzholz U; Schönfelder H
Nervenarzt; 1972 Oct; 43(10):531-2. PubMed ID: 4628192
[No Abstract] [Full Text] [Related]
19. L-dopa and amantadine for Parkinsonism.
Drug Ther Bull; 1970 Aug; 8(17):65-7. PubMed ID: 5480244
[No Abstract] [Full Text] [Related]
20. [Therapeutic association of L-dopa and an inhibitor of peripheral decarboxylase in Parkinsonism. Preliminary results].
De Divitiis E; Cerillo A; Tata MR; Decina A
Acta Neurol (Napoli); 1973; 28(2):208-12. PubMed ID: 4709076
[No Abstract] [Full Text] [Related]
[Next] [New Search]
